ABBVie today announced the presentation of new data on RINVOQ ® SKYRIZI ® and HUMIRA ® across multiple rheumatic diseases at the American College of Rheumatology's annual meeting to be held virtually Nov. 3-9 . A total of 38 abstracts, including two oral presentations and one plenary session presentation, will be presented from a broad range of studies in rheumatoid arthritis, psoriatic arthritis and ankylosing .
February 26, 2021 05:15 AM
United Center to become federal mass vaccination site • Biotech startup Jaguar Gene Therapy launches • The logistical challenge of a third vaccine
Crain s Health Pulse is your source for actionable, exclusive and inside news on the health care industry.
Alacoolwiki/Wikimedia Commons
UNITED CENTER TO BECOME VACCINATION SITE AIMED AT UNDERSERVED POPULATIONS: The United Center will become a mass vaccination site as soon as next month, top federal, state and local officials are expected to announce today.
The site on the city s West Side will be capable of inoculating 5,000 to 7,000 people a day and is part of a larger effort to increase vaccine access for minority populations, who have been hardest hit by the pandemic but have been slow to receive doses so far.
ABBVie today announced that the U.S. Food and Drug Administration approved HUMIRA ® for the treatment of moderately to severely active ulcerative colitis in pediatric patients 5 years of age and older. In clinical trials, HUMIRA induced clinical remission at Week 8 and maintained remission at Week 52 in patients who responded at Week 8. 1,2 “Ulcerative colitis can have a profound effect on children and for too …
ABBVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) approved HUMIRA ® (adalimumab) for the treatment of moderately to severely active ulcerative colitis in pediatric patients 5 years of age and older. In clinical trials, HUMIRA induced clinical remission at Week 8 and maintained remission at Week 52 in patients who responded at Week 8. 1,2
HUMIRA® (adalimumab) Receives FDA Approval to Treat Pediatric Patients Living with Moderately to Severely Active Ulcerative Colitis prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.